Navigation Links
Soluble IL-4 Receptor - A new boon for asthmatics

Bronchial asthma, the disease which is never an easy combat for any practising physician, is now being avenged by a new drug. A soluble interleukin-4 receptor (IL-4R), which acts as an IL-4 antagonist, appears to be safe and effective in preventing a decline in lung function and in preventing asthma symptoms.

In their study, Dr. Larry C. Borish, from the University of Virginia Health Sciences Center in Charlottesville, and colleagues randomly selected 62 patients with symptoms pertaining to moderate persistent asthma. They were stopped from inhaling corticosteroids and were divided into two groups. In one group IL-4 receptor were given and to the other group placebo was given.

It was found that, after a 12-week trial, those in the IL-4R group,there was no decline in FEV1; however, lung function did decline among those receiving placebo.

This study is "the first...to demonstrate the potential clinical efficacy of a TH2 inhibitor for the treatment of asthma," the investigators note.

This soluble IL-4 receptor, which isn't a corticosteroid, selectivelyinhibits allergic mechanisms will be a new boon in the treatment strategy of asthma.

"These data demonstrate the critical role of IL-4 in the pathogenesis of asthma and the potential benefit of this approach to therapy," Dr. Borish and colleagues conclude.
'"/>




Page: 1

Related medicine news :

1. Soluble Ingredient Can Make Fatty Fast Foods Healthier
2. Toll-like Receptor (Tlr3) Attachment Leads To Lethal Encephalitis
3. Genetic Variation In Bitter-Taste Receptor Gene Increases Alcoholic Risk
4. Calcium Receptor Vital For Stem Cell Migration to Bone Marrow
5. Researchers Identify Lung Failure Therapy Receptor
6. Effects Of Certain Food Related To Single Pain Receptors
7. Receptor for H.pylori Identified in Stomach
8. Functional Differences In Estrogen Receptor Could Be A Therapeutic Target
9. Schizophrenia Complicates With Altered Receptor Activity
10. Definite Connection Between Receptor Levels and Cocaine Abuse Reveals PET Imaging
11. Aromatase Inhibitors Better Than Tamoxifen For Treating Receptor-Positive Early Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... ... September 21, 2017 , ... The American ... Health Services for professionals in the addiction treatment industry entitled: Special Investigations ... , Insurance companies and state and federal governments are increasingly scrutinizing the addiction ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... communities, nine governmental public health departments have been awarded five-year accreditation status through ... that the benefits of being served by a PHAB-accredited health department now ...
(Date:9/21/2017)... ... September 21, 2017 , ... Innovatum will demonstrate capabilities of ... Healthcare Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development ... improving patient safety. , Microscan , a global technology leader in ...
(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, Fumie and Kentaro Mune, ... and 8th October at Miranda Kuo Gallery on Lower East Side, NYC. This exhibition ... Kodo mat. Wanderlust , one of the largest US yoga online media outlets ...
(Date:9/21/2017)... ... September 21, 2017 , ... Sagora Senior Living, ... Isle at Kingwood Assisted Living and Memory Care located at 24025 Kingwood Place ... 55 assisted living apartments, 43 memory care apartments and 23 extended care apartments. ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: